Sub-Q Bionics Closes $1.5M Pre-Seed for Lymphedema Care
Sub-Q Bionics, a medical device company developing next-generation solutions to improve care for patients living with lymphedema, today announced the successful close of its $1.5...
Tag : Pharma
Frontier Medicines Licenses FMC-220 with LG Chem
LG Chem will receive worldwide rights to FMC-220 outside of Greater China; Frontier will retain full ownership within Greater China Frontier will receive an upfront...
Meiji Seika Pharma Invests in Centivax Universal Vaccine
Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office:...
Biocytogen Licenses RenNano® Antibody Discovery Platform
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with...
AviadoBio Advances AVB-101 Gene Therapy Phase 1/2 Cohort
Early biomarker and safety data show encouraging signals with plans to present additional data in 2H 2026 AviadoBio secures strategic investment from The Alzheimer’s Drug...
Broken String Biosciences Rebrands Amid Strategic Evolution
Rebrand follows appointment of new leadership as company drives commercialization of INDUCE-seq platform to address regulatory gaps in off-target reporting for gene editing programs Broken...
AROA Biosurgery Reports Symphony™ Trial Meets Primary Endpoint
Aroa Biosurgery Limited today announced completion of its randomised controlled trial (RCT) evaluating Symphony, with a preliminary study read-out indicating the trial achieved its primary...
Merz Aesthetics Gains EU Approval for Two New BELOTERO® Indications
Merz Aesthetics®, the world’s largest dedicated medical aesthetics business, is pleased to announce that BELOTERO® Balance has received EU approval for two additional indications: the treatment...
Neion Bio Emerges with Multi-Product Biosimilar Partnership
Neion Bio, a biotechnology company revolutionizing the production of biologic medicines, today announced its emergence from stealth and the signing of its first co-development and...
Lunai Bioworks Acquires BBB Delivery Platform for CNS Therapies
Lunai Bioworks, Inc. (NASDAQ: LNAI) today announced it has executed a binding $20 million strategic transaction to acquire blood-brain barrier (BBB) delivery technology and central nervous...
Keymed Biosciences Reports 2025 Annual Results & Updates
Keymed Biosciences (HKEX: 02162) announced its 2025 annual results. Total revenue in 2025 was approximately RMB 720 million, a 67% year-on-year increase. This included around...
Seaport Therapeutics Publishes GlyphAllo Prodrug Study in Humans
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value,...
Invivoscribe Expands IVDR Portfolio with IdentiClone Dx Assay
IdentiClone® Dx IGH is the first IVDR-certified assay for the detection of clonal immunoglobulin gene rearrangements in patients with suspected B-cell lymphoproliferative disease. Invivoscribe, a global leader in...
Dr. Walter Koroshetz Joins APDA Scientific Advisory Board
Renowned neuroscience leader to help evaluate and guide Parkinson’s research funding The American Parkinson Disease Association (APDA) is proud to announce that Dr. Walter Koroshetz, a highly...
HanchorBio Moves Toward TWSE Innovation Board Listing
Listing milestone positions HanchorBio to strengthen institutional visibility, advance its FBDB™ platform, and expand a growing pipeline spanning oncology and broader immune-mediated diseases HanchorBio, Inc. (TPEx:...